129 related articles for article (PubMed ID: 10353335)
21. Adenosine kinase inhibitors. 1. Synthesis, enzyme inhibition, and antiseizure activity of 5-iodotubercidin analogues.
Ugarkar BG; DaRe JM; Kopcho JJ; Browne CE; Schanzer JM; Wiesner JB; Erion MD
J Med Chem; 2000 Jul; 43(15):2883-93. PubMed ID: 10956196
[TBL] [Abstract][Full Text] [Related]
22. Recent developments in the discovery of novel adenosine kinase inhibitors: mechanism of action and therapeutic potential.
McGaraughty S; Cowart M; Jarvis MF
CNS Drug Rev; 2001; 7(4):415-32. PubMed ID: 11830758
[TBL] [Abstract][Full Text] [Related]
23. Partial characterization of kainic acid-induced striatal dopamine release using in vivo microdialysis.
Carrozza DP; Ferraro TN; Golden GT; Reyes PF; Hare TA
Brain Res; 1991 Mar; 543(1):69-76. PubMed ID: 2054676
[TBL] [Abstract][Full Text] [Related]
24. Increases in interstitial adenosine and cerebral blood flow with inhibition of adenosine kinase and adenosine deaminase.
Sciotti VM; Van Wylen DG
J Cereb Blood Flow Metab; 1993 Mar; 13(2):201-7. PubMed ID: 8436611
[TBL] [Abstract][Full Text] [Related]
25. Transient use of a systemic adenosine kinase inhibitor attenuates epilepsy development in mice.
Sandau US; Yahya M; Bigej R; Friedman JL; Saleumvong B; Boison D
Epilepsia; 2019 Apr; 60(4):615-625. PubMed ID: 30815855
[TBL] [Abstract][Full Text] [Related]
26. The adenosine kinase inhibitor ABT-702 augments EEG slow waves in rats.
Radek RJ; Decker MW; Jarvis MF
Brain Res; 2004 Nov; 1026(1):74-83. PubMed ID: 15476699
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of cellular adenosine triphosphate levels in PC12 cells by extracellular adenosine.
Fujimori H; Yasuda M; Pan-Hou H
Biol Pharm Bull; 2002 Mar; 25(3):307-11. PubMed ID: 11913523
[TBL] [Abstract][Full Text] [Related]
28. Location of adenosine release and adenosine A2 receptors to rat striatal neurons.
Wojcik WJ; Neff NH
Life Sci; 1983 Aug; 33(8):755-63. PubMed ID: 6310299
[TBL] [Abstract][Full Text] [Related]
29. Potentiation of formalin-evoked adenosine release by an adenosine kinase inhibitor and an adenosine deaminase inhibitor in the rat hind paw: a microdialysis study.
Liu XJ; White TD; Sawynok J
Eur J Pharmacol; 2000 Nov; 408(2):143-52. PubMed ID: 11080520
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of adenosine kinase in epileptic hippocampus contributes to epileptogenesis.
Gouder N; Scheurer L; Fritschy JM; Boison D
J Neurosci; 2004 Jan; 24(3):692-701. PubMed ID: 14736855
[TBL] [Abstract][Full Text] [Related]
31. Kainate receptors coupled to the evoked release of [3H]-gamma-aminobutyric acid from striatal neurons in primary culture: potentiation by lithium ions.
Weiss S; Kemp DE; Bauce L; Tse FW
Mol Pharmacol; 1990 Aug; 38(2):229-36. PubMed ID: 2166903
[TBL] [Abstract][Full Text] [Related]
32. Anti-inflammatory effects of ABT-702, a novel non-nucleoside adenosine kinase inhibitor, in rat adjuvant arthritis.
Boyle DL; Kowaluk EA; Jarvis MF; Lee CH; Bhagwat SS; Williams M; Firestein GS
J Pharmacol Exp Ther; 2001 Feb; 296(2):495-500. PubMed ID: 11160636
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic potential of adenosine kinase inhibitors.
Kowaluk EA; Jarvis MF
Expert Opin Investig Drugs; 2000 Mar; 9(3):551-64. PubMed ID: 11060695
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic potential of adenosine kinase inhibition-Revisited.
Jarvis MF
Pharmacol Res Perspect; 2019 Aug; 7(4):e00506. PubMed ID: 31367385
[TBL] [Abstract][Full Text] [Related]
35. Adenosine kinase inhibitors. 2. Synthesis, enzyme inhibition, and antiseizure activity of diaryltubercidin analogues.
Ugarkar BG; Castellino AJ; DaRe JM; Kopcho JJ; Wiesner JB; Schanzer JM; Erion MD
J Med Chem; 2000 Jul; 43(15):2894-905. PubMed ID: 10956197
[TBL] [Abstract][Full Text] [Related]
36. Adenosine kinase inhibitors. 5. Synthesis, enzyme inhibition, and analgesic activity of diaryl-erythro-furanosyltubercidin analogues.
Boyer SH; Ugarkar BG; Solbach J; Kopcho J; Matelich MC; Ollis K; Gomez-Galeno JE; Mendonca R; Tsuchiya M; Nagahisa A; Nakane M; Wiesner JB; Erion MD
J Med Chem; 2005 Oct; 48(20):6430-41. PubMed ID: 16190769
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of adenosine kinase by phosphonate and bisphosphonate derivatives.
Park J; Singh B; Gupta RS
Mol Cell Biochem; 2006 Feb; 283(1-2):11-21. PubMed ID: 16444581
[TBL] [Abstract][Full Text] [Related]
38. Crystal structures of human adenosine kinase inhibitor complexes reveal two distinct binding modes.
Muchmore SW; Smith RA; Stewart AO; Cowart MD; Gomtsyan A; Matulenko MA; Yu H; Severin JM; Bhagwat SS; Lee CH; Kowaluk EA; Jarvis MF; Jakob CL
J Med Chem; 2006 Nov; 49(23):6726-31. PubMed ID: 17154503
[TBL] [Abstract][Full Text] [Related]
39. The effect of adenosine metabolism inhibition and nucleotide precursor supply on adenosine production in human heart endothelial cells.
Smolenski RT; Kalsi KK; Gray CC; Zych M; Kochan Z; Yacoub MH
Adv Exp Med Biol; 2000; 486():163-6. PubMed ID: 11783477
[No Abstract] [Full Text] [Related]
40. Differential glutamate-dependent and glutamate-independent adenosine A1 receptor-mediated modulation of dopamine release in different striatal compartments.
Borycz J; Pereira MF; Melani A; Rodrigues RJ; Köfalvi A; Panlilio L; Pedata F; Goldberg SR; Cunha RA; Ferré S
J Neurochem; 2007 Apr; 101(2):355-63. PubMed ID: 17254024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
